Brief: China Resources Pharmaceutical Posts HY Profit Attributable HK$3.04 Bln
31/08/2023 05:09
Aug 31 (Reuters) - China Resources Pharmaceutical Group
Ltd 3320.HK :
* HY PROFIT ATTRIBUTABLE HK$3.04 BILLION VERSUS HK$3.03
BILLION
* HY REVENUE HK$138.94 BLN VS HK$125.7 BLN
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals